331 results on '"Ertl, Hildegund C. J."'
Search Results
2. Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression
3. Peptides as Molecular Probes of Immune Responses
4. PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
5. Historical Progression from Nerve Tissue-Based Rabies Vaccines to Recombinant Biologics for Humans and Companion Animals
6. Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
7. Novel Rabies Vaccines
8. Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection
9. Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma
10. 2320. Novel checkpoint modifier lowers T cell activation threshold and enhances and broadens vaccine-induced responses to chronic viral infections
11. Activated CD4⁺CCR5⁺ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques
12. Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health
13. Immunogenicity and toxicity of AAV gene therapy
14. Pandemic Influenza Vaccines
15. Immune response to influenza vaccination in the elderly is altered by chronic medication use
16. Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?
17. A One Medicine Mission for an Effective Rabies Therapy
18. Vaccine Design: Replication-Defective Adenovirus Vectors
19. INFLUENZA A VIRUS PANDEMICS
20. Pre-Clinical Testing of Two Serologically Distinct Chimpanzee-Origin Adenovirus Vectors Expressing Spike of SARS-CoV-2
21. Cyclosporin a Provides No Sustained Immunologic Benefit to Persons with Chronic HIV-1 Infection Starting Suppressive Antiretroviral Therapy. Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138
22. The Natural Stilbenoid (–)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants
23. Additional file 1 of Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection
24. Additional file 3 of Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection
25. T cell responses to adenoviral vectors expressing the SARS-CoV-2 nucleoprotein
26. Additional file 2 of Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection
27. An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector
28. VACCINE-INDUCED PROTECTION AGAINST SIMIAN IMMUNODEFICIENCY VIRUS: ABSTRACT #42
29. T Cell-Mediated Immune Responses to AAV and AAV Vectors
30. CD8+ T-cell responses to adeno-associated virus capsid in humans
31. DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins
32. Low scale multiple array synthesis and DNA hybridization of peptide nucleic acids
33. The Natural T-Helper Cell Epitope Repertoire is Unlikely to Contain Glycopeptides with Extended Carbohydrate Side-Chains
34. T and B Cell Metabolism in Older Adults
35. Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells
36. DNA Vaccines
37. Cytokines and Immunomodulatory Ligands as Genetic Adjuvants
38. Activation of the Innate Immune System by DNA Vaccines
39. New Rabies Vaccines for Use in Humans
40. Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
41. Gene Therapy for HIV and Chronic Infections Preface
42. A PartialE3Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products
43. Starved and Asphyxiated: How Can CD8+ T Cells within a Tumor Microenvironment Prevent Tumor Progression
44. Virus-specific T-cell sensitization: Requirements for vaccinia virus-specific T-cell sensitization in vivo
45. Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis.
46. Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation
47. Activated CD4 + CCR5 + T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques
48. Vaccine Design: Replication-Defective Adenovirus Vectors.
49. Genetic Adjuvants
50. The Effect of Adjuvanting Cancer Vaccines with Herpes Simplex Virus Glycoprotein D on Melanoma-Driven CD8+ T Cell Exhaustion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.